Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3276363
Max Phase: Preclinical
Molecular Formula: C21H24ClNO3
Molecular Weight: 337.42
Molecule Type: Small molecule
Associated Items:
ID: ALA3276363
Max Phase: Preclinical
Molecular Formula: C21H24ClNO3
Molecular Weight: 337.42
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.OC(CNCCOc1cccc2ccccc12)COc1ccccc1
Standard InChI: InChI=1S/C21H23NO3.ClH/c23-18(16-25-19-9-2-1-3-10-19)15-22-13-14-24-21-12-6-8-17-7-4-5-11-20(17)21;/h1-12,18,22-23H,13-16H2;1H
Standard InChI Key: GDDYKXSUZYDMLQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 337.42 | Molecular Weight (Monoisotopic): 337.1678 | AlogP: 3.25 | #Rotatable Bonds: 9 |
Polar Surface Area: 50.72 | Molecular Species: BASE | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.76 | CX LogP: 3.45 | CX LogD: 2.08 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.59 | Np Likeness Score: -0.60 |
1. Smith LH, Tucker H.. (1977) beta-Adrenergic blocking agents. 17. 1-Phenoxy-3-phenoxyalkylamino-2-propanols and 1-alkoxyalkylamino-3-phenoxy-2-propanols., 20 (12): [PMID:22750] [10.1021/jm00222a022] |
Source(1):